![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.135 | -2.91% | 4.51 | 4.41 | 4.99 | 4.53 | 4.51 | 4.53 | 189,892 | 11:53:49 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.51 | 9.35M |
Date | Subject | Author | Discuss |
---|---|---|---|
20/7/2020 09:25 | This is great news for shareholders, but I have one question: what would happen if a vaccine was developed for Covid-19? Surely if the population were vaccinated there would be no requirement for this breakthrough? | ![]() craffert | |
20/7/2020 09:24 | COPD trials I would guess will be positive also. They were almost complete until covid trails begun. Thats a multi billion payload for SNG also. | tidy 2 | |
20/7/2020 09:23 | Agree totally Waterloo and they will need to up production quickly. Even though this is already happening its going to take a major to meet demand. | ![]() freedosh | |
20/7/2020 09:22 | Gulp. NORTH | tidy 2 | |
20/7/2020 09:21 | They will have to do a deal with one of the big players. How many doses do you think the UK alone will want in reserve for this and any future virus's? Blockbuster potential which means over $1bn a year in sales. | ![]() waterloo01 | |
20/7/2020 09:20 | 500% is so so on the cards :))) | ![]() g2theary | |
20/7/2020 09:20 | finnCap: "Synairgen (SNG): Corp COVID-19 treatment – positive Phase II data Synairgen released very positive results from its Phase II trial of SNG001 in hospitalised COVID-19 patients – a 79% reduction in patients developing severe disease or death, with those on SNG001 more than twice as likely to recover over the treatment period than those on placebo. Both were statistically significant. Valuing the COVID-19 opportunity is nigh on impossible; however, we upgrade our target price to 360p but recognise that this could go substantially higher, based on upcoming discussions with regulators, which should clarify the route to market and the potential for buying SNG001 ahead of the winter 2020 flu season and the possibility of a second wave of COVID-19." | ![]() someuwin | |
20/7/2020 09:19 | I'm top slicing at 320. Its only just begun | ![]() bobaxe1 | |
20/7/2020 09:17 | You could say this is a cure as much as a treatment. Bit of a Eureka moment in the lab. | tidy 2 | |
20/7/2020 09:17 | I made the mistakes selling avct and Tils way too early not making that mistake here. | ![]() fund1 | |
20/7/2020 09:16 | Just had my breakfast, my pf is looking great again, hey paradise lol lol.Well done nobby | ![]() bobaxe1 | |
20/7/2020 09:15 | 224% - read that bbc article - | ![]() tomboyb | |
20/7/2020 09:14 | Ah ha - someone put some WD-40 on the charting machine. | ![]() freedosh | |
20/7/2020 09:13 | Did peeps spot the 750,000 buy from Friday that was shown first thing today? Can't believe for a single moment that they knew what was happening! | ![]() freedosh |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions